Rivaroxaban Use is Associated with Reduced Risk of Myocardial Infarction-Insights from a Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials

被引：0
|
作者：
Chatterjee, Saurav [1 ]
Sharma, Abbishek [1 ]
Uchino, Ken [2 ]
Blondi-Zoccai, Giuseppe [3 ]
Lichstein, Edgar [1 ]
Mukherjee, Debabrata [4 ]
机构：
[1] Maimonides Hosp, Brooklyn, NY 11219 USA
[2] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[3] Sapienza Univ Rome, Dept Medicosurg Sci & Biotechnol, Latina, Italy
[4] Texas Tech Univ, Hlth Sci Ctr, Div Cardiol, El Paso, TX USA
来源：
CIRCULATION | 2012年 / 126卷 / 21期
关键词：
Factor xa; Myocardial Infarction;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
9013
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Rivaroxaban and risk of myocardial infarction: insights from a meta- analysis and trial sequential analysis of randomized clinical trials
    Chatterjee, Saurav
    Sharma, Abhishek
    Uchino, Ken
    Biondi-Zoccai, Giuseppe
    Lichstein, Edgar
    Mukherjee, Debabrata
    CORONARY ARTERY DISEASE, 2013, 24 (08) : 628 - 635
  • [2] Sulphonylureas Are Not Associated with Increased Mortality: Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials
    Rados, Dimitris V.
    Pinto, Lana C.
    Remonti, Luciana R.
    Canani, Luis H.
    Leitao, Cristiane B.
    Gross, Jorge L.
    DIABETES, 2015, 64 : A5 - A5
  • [3] Apixaban and risk of myocardial infarction: meta-analysis of randomized controlled trials
    Tornyos, Adrienn
    Vorobcsuk, Andras
    Kupo, Peter
    Aradi, Daniel
    Kehl, Daniel
    Komocsi, Andras
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2015, 40 (01) : 1 - 11
  • [4] Apixaban and risk of myocardial infarction: meta-analysis of randomized controlled trials
    Adrienn Tornyos
    András Vorobcsuk
    Péter Kupó
    Dániel Aradi
    Dániel Kehl
    András Komócsi
    Journal of Thrombosis and Thrombolysis, 2015, 40 : 1 - 11
  • [5] Clinical Outcomes with β-Blockers for Myocardial Infarction: A Meta-analysis of Randomized Trials
    Bangalore, Sripal
    Makani, Harikrishna
    Radford, Martha
    Thakur, Kamia
    Toklu, Bora
    Katz, Stuart D.
    DiNicolantonio, James J.
    Devereaux, P. J.
    Alexander, Karen P.
    Wetterslev, Jorn
    Messerli, Franz H.
    AMERICAN JOURNAL OF MEDICINE, 2014, 127 (10): : 939 - 953
  • [6] Meta-Analysis of Randomized Controlled Trials on Risk of Myocardial Infarction from the Use of Oral Direct Thrombin Inhibitors
    Artang, Ramin
    Rome, Eric
    Nielsen, Jorn Dalsgaard
    Vidaillet, Humberto J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (12): : 1973 - 1979
  • [7] Reduction of C-reactive protein is associated with reduced risk of myocardial infarction. A meta-analysis of 16 randomized trials
    Savarese, G.
    Parente, A.
    D'amore, C.
    Reiner, M.
    Trimarco, B.
    Filardi, P. Perrone
    EUROPEAN HEART JOURNAL, 2014, 35 : 568 - 569
  • [8] Atrial fibrillation is associated with an increased risk of myocardial infarction: Insights from a meta-analysis
    Guo, Xue-Yuan
    Li, Na
    Du, Xin
    Bai, Rong
    Yu, Rong-Hui
    Long, De-Yong
    Tang, Ri-Bo
    Sang, Cai-Hua
    Jiang, Chen-Xi
    Ning, Man
    Li, Song-Nan
    Liu, Nian
    Dong, Jian-Zeng
    Ma, Chang-Sheng
    ATHEROSCLEROSIS, 2016, 254 : 1 - 7
  • [9] Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials
    Ning, Guang-Zhi
    Kan, Shun-Li
    Chen, Ling-Xiao
    Lei Shangguan
    Feng, Shi-Qing
    Zhou, Yue
    SCIENTIFIC REPORTS, 2016, 6
  • [10] Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials
    Guang-Zhi Ning
    Shun-Li Kan
    Ling-Xiao Chen
    Lei Shangguan
    Shi-Qing Feng
    Yue Zhou
    Scientific Reports, 6
12345